Cel Sci Corporation (CVM)

[lightrock]

The 5% thing in our case is bolstered by lack of effectiveness of placebo in cancer studies.

Our 5% is not confuse-able with placebo effect

14% at year 5 is 2/3rds of a year added lifespan on average to that population

For immunotherapies that's not 1-3 months, that's substantial - especially into and beyond year 5

... people are alive today that probably wouldn't be otherwise ...